Treatment with Simvastatin in Patients with Alzheimer’s Disease Lowers Both α- and β-Cleaved Amyloid Precursor Protein

Publisher： Karger

E-ISSN： 1421-9824|16|1|25-30

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.16, Iss.1, 2003-05, pp. : 25-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Simvastatin Treatment on the Amyloid Precursor Protein and Brain Cholesterol Metabolism in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 5-6, 2005-04 ,pp. : 256-265

Karger

Access to resources Recommend Favorite

Cholinesterase Inhibitor Affects the Amyloid Precursor Protein Isoforms in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 5-6, 2005-04 ,pp. : 345-348

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Levels of Amyloid Precursor Protein and Amyloid β-Peptide in Alzheimer’s Disease and Major Depression – Inverse Correlation with Dementia Severity

By  

European Neurology, Vol. 39, Iss. 2, 1998-02 ,pp. : 111-118

Karger

Access to resources Recommend Favorite

Reduced Expression of Amyloid Precursor Protein, Presenilin-1 and rab3a in Cortical Brain Regions in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 4, 2001-05 ,pp. : 243-250

Karger

Access to resources Recommend Favorite

Oral Glucose Loading Modulates Plasma β-Amyloid Level in Alzheimer’s Disease Patients: Potential Diagnostic Method for Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 34, Iss. 1, 2012-08 ,pp. : 25-30

Karger

Access to resources Recommend Favorite